Paresh C Gandhi
Examiner (ID: 305)
Most Active Art Unit | 2663 |
Art Unit(s) | 2663 |
Total Applications | 1 |
Issued Applications | 1 |
Pending Applications | 0 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17702726
[patent_doc_number] => 20220202732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => Metal Oxide Encapsulated Drug Compositions and Methods of Preparing the Same
[patent_app_type] => utility
[patent_app_number] => 17/695687
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 254
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695687
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/695687 | Metal oxide encapsulated drug compositions and methods of preparing the same | Mar 14, 2022 | Issued |
Array
(
[id] => 17828311
[patent_doc_number] => 20220265615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => Compositions and Methods for the Treatment of Amyotrophic Lateral Sclerosis, Parkinson?s Disease, Parkinson?s Disease with Dementia, Dementia with Lewy Bodies, and Multiple System Atrophy
[patent_app_type] => utility
[patent_app_number] => 17/689666
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17689666
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/689666 | Compositions and methods for the treatment of amyotrophic lateral sclerosis, parkinson's disease, parkinson's disease with dementia, dementia with lewy bodies, and multiple system atrophy | Mar 7, 2022 | Issued |
Array
(
[id] => 17654536
[patent_doc_number] => 20220175001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => Highly Soluble Rebaudioside D
[patent_app_type] => utility
[patent_app_number] => 17/679682
[patent_app_country] => US
[patent_app_date] => 2022-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17679682
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/679682 | Highly soluble Rebaudioside D | Feb 23, 2022 | Issued |
Array
(
[id] => 17654544
[patent_doc_number] => 20220175009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => NUTRITIONAL COMPOSITION AND INFANT FORMULA FOR PROMOTING DE NOVO MYELINATION
[patent_app_type] => utility
[patent_app_number] => 17/678672
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17678672
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/678672 | Nutritional composition and infant formula for promoting de novo myelination | Feb 22, 2022 | Issued |
Array
(
[id] => 19089691
[patent_doc_number] => 11951110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => 3, 7-diamino-10H-phenothiazine salts and their use
[patent_app_type] => utility
[patent_app_number] => 17/591306
[patent_app_country] => US
[patent_app_date] => 2022-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 17643
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17591306
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/591306 | 3, 7-diamino-10H-phenothiazine salts and their use | Feb 1, 2022 | Issued |
Array
(
[id] => 17593461
[patent_doc_number] => 20220143034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => PDE5 INHIBITOR POWDER FORMULATIONS AND METHODS RELATING THERETO
[patent_app_type] => utility
[patent_app_number] => 17/579981
[patent_app_country] => US
[patent_app_date] => 2022-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21024
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579981
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579981 | PDE5 inhibitor powder formulations and methods relating thereto | Jan 19, 2022 | Issued |
Array
(
[id] => 18931023
[patent_doc_number] => 11883417
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
[patent_app_type] => utility
[patent_app_number] => 17/577882
[patent_app_country] => US
[patent_app_date] => 2022-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 19832
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17577882
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/577882 | Methods and compositions related to glucocorticoid receptor antagonists and breast cancer | Jan 17, 2022 | Issued |
Array
(
[id] => 17783504
[patent_doc_number] => 11406606
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Formulation for inhibiting formation of 5-HT2B agonists and methods of using same
[patent_app_type] => utility
[patent_app_number] => 17/570683
[patent_app_country] => US
[patent_app_date] => 2022-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 8948
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570683
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/570683 | Formulation for inhibiting formation of 5-HT2B agonists and methods of using same | Jan 6, 2022 | Issued |
Array
(
[id] => 19179872
[patent_doc_number] => 11986446
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-21
[patent_title] => Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
[patent_app_type] => utility
[patent_app_number] => 17/562787
[patent_app_country] => US
[patent_app_date] => 2021-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13122
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17562787
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/562787 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | Dec 26, 2021 | Issued |
Array
(
[id] => 17532308
[patent_doc_number] => 20220110917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => USE OF GABOXADOL, GANAXOLONE AND ALLOPREGNANOLONE TO TREAT MOVEMENT DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/558195
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20939
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17558195
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/558195 | USE OF GABOXADOL, GANAXOLONE AND ALLOPREGNANOLONE TO TREAT MOVEMENT DISORDERS | Dec 20, 2021 | Pending |
Array
(
[id] => 19042258
[patent_doc_number] => 11931331
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => Compositions and methods for treating the eye
[patent_app_type] => utility
[patent_app_number] => 17/539776
[patent_app_country] => US
[patent_app_date] => 2021-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19006
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17539776
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/539776 | Compositions and methods for treating the eye | Nov 30, 2021 | Issued |
Array
(
[id] => 17471654
[patent_doc_number] => 20220079158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => PLANT ANTIMICROBIAL COMPOSITIONS INCLUDING AN EMULSIFIER AND/OR OZONE AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/532465
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532465
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/532465 | PLANT ANTIMICROBIAL COMPOSITIONS INCLUDING AN EMULSIFIER AND/OR OZONE AND METHODS OF USE | Nov 21, 2021 | Pending |
Array
(
[id] => 17460342
[patent_doc_number] => 20220073647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => APPLICATION OF PCSK9 INHIBITORS IN THE PREPARATION OF DRUGS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNE DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/533027
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17533027
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/533027 | APPLICATION OF PCSK9 INHIBITORS IN THE PREPARATION OF DRUGS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNE DISEASES | Nov 21, 2021 | Pending |
Array
(
[id] => 18603413
[patent_doc_number] => 11744853
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Method of administration and treatment
[patent_app_type] => utility
[patent_app_number] => 17/514653
[patent_app_country] => US
[patent_app_date] => 2021-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 37898
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17514653
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/514653 | Method of administration and treatment | Oct 28, 2021 | Issued |
Array
(
[id] => 18716484
[patent_doc_number] => 11793805
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Methods for treating antipsychotic-induced weight gain
[patent_app_type] => utility
[patent_app_number] => 17/505896
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5204
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17505896
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/505896 | Methods for treating antipsychotic-induced weight gain | Oct 19, 2021 | Issued |
Array
(
[id] => 19041766
[patent_doc_number] => 11930836
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => Nutritional composition and infant formula for promoting myelination of the brain
[patent_app_type] => utility
[patent_app_number] => 17/505781
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 65
[patent_no_of_words] => 23706
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17505781
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/505781 | Nutritional composition and infant formula for promoting myelination of the brain | Oct 19, 2021 | Issued |
Array
(
[id] => 19120072
[patent_doc_number] => 11964033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Dry composition for and methods for fabrication of dry compositions
[patent_app_type] => utility
[patent_app_number] => 17/505005
[patent_app_country] => US
[patent_app_date] => 2021-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 25
[patent_no_of_words] => 5049
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17505005
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/505005 | Dry composition for and methods for fabrication of dry compositions | Oct 18, 2021 | Issued |
Array
(
[id] => 17502562
[patent_doc_number] => 20220095664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => METHOD OF IMPROVING FLAVOR OF A COMPOSITION OF (D)-BETA-HYDROXYBUTYRIC ACID AND (D)-1,3 BUTANEDIOL AND USE AS A NUTRITIONAL SUPPLEMENT AND THERAPEUTIC AGENT
[patent_app_type] => utility
[patent_app_number] => 17/498193
[patent_app_country] => US
[patent_app_date] => 2021-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10326
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17498193
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/498193 | Method of improving flavor of a composition of (D)-beta-hydroxybutyric acid and (D)-1,3 butanediol and use as a nutritional supplement and therapeutic agent | Oct 10, 2021 | Issued |
Array
(
[id] => 17398135
[patent_doc_number] => 20220040225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => METHOD OF ADMINISTRATION AND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/497799
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497799
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/497799 | Method of administration and treatment | Oct 7, 2021 | Issued |
Array
(
[id] => 18716508
[patent_doc_number] => 11793830
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Method of administration and treatment
[patent_app_type] => utility
[patent_app_number] => 17/497794
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 37732
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497794
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/497794 | Method of administration and treatment | Oct 7, 2021 | Issued |